Stockreport

Omeros: Novo Nordisk's Licensing Deal Sends Shares Soaring, Makes Bull Case [Seeking Alpha]

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF The deal provides OMER with critical funding, alleviating bankruptcy concerns and supporting operations through 2027 as it pursues FDA approval for narsoplimab. Zalte [Read more]